Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis

doi:10.4330/wjc.v13.i4.82

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6929)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

488

WORD

215

HTML

4033

Figures (1-5)

287

Tables (1-2)

220

Sum=5243

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

241

Download

481

Sum=722

Publishing Process of This Article

Item

Count

Browse

366

Download

598

Sum=964

Apr 26, 2021 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Apr 26, 2021; 13(4): 82-94
Published online Apr 26, 2021. doi: 10.4330/wjc.v13.i4.82

Full Size Figure Download Figure

Figure 2 Risk of bias assessment of included studies using risk of bias in non-randomized studies-of interventions tool.

Citation: Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94
URL: https://www.wjgnet.com/1949-8462/full/v13/i4/82.htm
DOI: https://dx.doi.org/10.4330/wjc.v13.i4.82